1998
DOI: 10.1016/s0039-6257(98)00023-x
|View full text |Cite
|
Sign up to set email alerts
|

Proliferative Vitreoretinopathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
253
5
18

Year Published

2002
2002
2014
2014

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 359 publications
(279 citation statements)
references
References 100 publications
3
253
5
18
Order By: Relevance
“…9 The present study does not support this view; the specialist teams achieved markedly better anatomical results even in single-hole one or two quadrant cases. If confirmed elsewhere this has important consequences in relation to the planning of ophthalmic services, particularly in relation to macula-on detachments which are generally regarded as rather urgent.…”
Section: 'Simple' Detachmentscontrasting
confidence: 90%
See 1 more Smart Citation
“…9 The present study does not support this view; the specialist teams achieved markedly better anatomical results even in single-hole one or two quadrant cases. If confirmed elsewhere this has important consequences in relation to the planning of ophthalmic services, particularly in relation to macula-on detachments which are generally regarded as rather urgent.…”
Section: 'Simple' Detachmentscontrasting
confidence: 90%
“…8 However, PVR might arise from overvigorous cryotherapy. 9 There is clearly a balance to strike between under and over-treatment. In this context the marked reduction in the proportion of conventional operations, which were 'open', is interesting.…”
Section: Reasons For Failurementioning
confidence: 99%
“…As they use to grow into the vitreous body (and induce alterations there), this phenomenon is called proliferative vitreoretinopathy (PVR). 56 Proceeding PVR then leads to folding and detachment of the retina (Figure 3b), excessive neurodegeneration and blindness.…”
Section: Mü Ller Cells and Retinopathymentioning
confidence: 99%
“…[34][35][36] Adjunctive agents may specifically or non-specifically target: (a) the proliferating cell types known to be involved in PVR; (b) the production and subsequent contraction of the extracellular matrix; (c) the initial deposition of fibrin which may serve as the scaffold for subsequent membrane formation; and (d) the various growth factors which have been documented to mediate PVR development. 37 A number of agents have been analysed in experimental systems and in uncontrolled clinical trials (for a detailed discussion see Charteris 34 ).…”
Section: Adjunctive Treatmentmentioning
confidence: 99%